Glipizide Tablets
Formulated to target blood glucose levels, intended to manage type 2 diabetes.
Strengths: 5 · 10mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Glucotrol
- Therapeutic class
Sulfonylurea
- Pharmacological class
Sulfonylurea Antidiabetic
- Contraindications
hypersensitivity to glipizide; type 1 diabetes; diabetic ketoacidosis
- Minor side effects
hypoglycaemia; dizziness; nausea
- Moderate side effects
weight gain; skin rash
- Dosage forms
Tablet
- Administration route
Oral use
- Patient summary
Formulated to target blood glucose levels, intended to manage type 2 diabetes.
- Prescription status
POM
- Manufacturer
Pfizer
- Onset Time
30–60 minutes
- Duration
12–24 hours
- Storage instructions
Store at room temperature in a dry place.
- Drug interactions
alcohol; NSAIDs; beta blockers
- Age restrictions
Adults only
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Precautions and warnings
risk of hypoglycaemia; carry sugar source; regular blood glucose monitoring necessary; may impair ability to drive or operate machinery
Serious side effects
severe hypoglycaemia — requires immediate medical attention; agranulocytosis — requires immediate medical attention
Mechanism of action
Glipizide is a second-generation sulfonylurea that acts by increasing insulin release from the pancreatic beta cells. It effectively reduces blood sugar levels in patients who retain some pancreatic function.
Glipizide Tablets
Formulated to target blood glucose levels, intended to manage type 2 diabetes.
Editorial Notes
- Active ingredient(s): Glipizide
- Listed indication(s): Type 2 Diabetes Mellitus
Available option
- 240 tablets - 10 mg1392-10-mg-16712